Overview

Effects of Administration of Fostamatinib on Blood Concentrations of Pioglitazone in Healthy Subjects

Status:
Completed
Trial end date:
2011-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the drug interaction between fostamatinib and pioglitazone by comparing the safety, tolerability and plasma concentration of pioglitazone when administered alone and with fostamatinib in healthy subjects.
Phase:
Phase 1
Details
Lead Sponsor:
AstraZeneca
Treatments:
Pioglitazone